Clinical Trial

Optimization of Respiratory Effort With Titrated Sedation in AHRF

Study acronym: OPTIREST
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Prospective, observational, monocentric study to assess the physiological effects of dexmedetomidine and remifentanil in spontaneously breathing patients with acute hypoxemic respiratory failure receiving high-flow nasal oxygen.
Trial Details
NCT Number NCT07679932
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions AHRF
Enrollment 40 participants
Start Date 2026-07
Primary Completion 2028-06 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-01